Skip to main content
NCBI home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1992 Sep;56(3):395–411. doi: 10.1128/mr.56.3.395-411.1992

Agents that increase the permeability of the outer membrane.

M Vaara 1
PMCID: PMC372877  PMID: 1406489

Abstract

The outer membrane of gram-negative bacteria provides the cell with an effective permeability barrier against external noxious agents, including antibiotics, but is itself a target for antibacterial agents such as polycations and chelators. Both groups of agents weaken the molecular interactions of the lipopolysaccharide constituent of the outer membrane. Various polycations are able, at least under certain conditions, to bind to the anionic sites of lipopolysaccharide. Many of these disorganize and cross the outer membrane and render it permeable to drugs which permeate the intact membrane very poorly. These polycations include polymyxins and their derivatives, protamine, polymers of basic amino acids, compound 48/80, insect cecropins, reptilian magainins, various cationic leukocyte peptides (defensins, bactenecins, bactericidal/permeability-increasing protein, and others), aminoglycosides, and many more. However, the cationic character is not the sole determinant required for the permeabilizing activity, and therefore some of the agents are much more effective permeabilizers than others. They are useful tools in studies in which the poor permeability of the outer membrane poses problems. Some of them undoubtedly have a role as natural antibiotic substances, and they or their derivatives might have some potential as pharmaceutical agents in antibacterial therapy as well. Also, chelators (such as EDTA, nitrilotriacetic acid, and sodium hexametaphosphate), which disintegrate the outer membrane by removing Mg2+ and Ca2+, are effective and valuable permeabilizers.

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aketagawa J., Miyata T., Ohtsubo S., Nakamura T., Morita T., Hayashida H., Miyata T., Iwanaga S., Takao T., Shimonishi Y. Primary structure of limulus anticoagulant anti-lipopolysaccharide factor. J Biol Chem. 1986 Jun 5;261(16):7357–7365. [PubMed] [Google Scholar]
  2. Alatossava T., Jütte H., Kuhn A., Kellenberger E. Manipulation of intracellular magnesium content in polymyxin B nonapeptide-sensitized Escherichia coli by ionophore A23187. J Bacteriol. 1985 Apr;162(1):413–419. doi: 10.1128/jb.162.1.413-419.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Almeida R. P., Melchior M., Campanelli D., Nathan C., Gabay J. E. Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteases. Biochem Biophys Res Commun. 1991 Jun 14;177(2):688–695. doi: 10.1016/0006-291x(91)91843-2. [DOI] [PubMed] [Google Scholar]
  4. Ando K., Natori S. Inhibitory effect of sarcotoxin IIA, an antibacterial protein of Sarcophaga peregrina, on growth of Escherichia coli. J Biochem. 1988 Apr;103(4):735–739. doi: 10.1093/oxfordjournals.jbchem.a122337. [DOI] [PubMed] [Google Scholar]
  5. Ando K., Natori S. Molecular cloning, sequencing, and characterization of cDNA for sarcotoxin IIA, an inducible antibacterial protein of Sarcophaga peregrina (flesh fly). Biochemistry. 1988 Mar 8;27(5):1715–1721. doi: 10.1021/bi00405a050. [DOI] [PubMed] [Google Scholar]
  6. Bangalore N., Travis J., Onunka V. C., Pohl J., Shafer W. M. Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem. 1990 Aug 15;265(23):13584–13588. [PubMed] [Google Scholar]
  7. Bell A., Bains M., Hancock R. E. Pseudomonas aeruginosa outer membrane protein OprH: expression from the cloned gene and function in EDTA and gentamicin resistance. J Bacteriol. 1991 Nov;173(21):6657–6664. doi: 10.1128/jb.173.21.6657-6664.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bennett G. M., Seaver A., Calcott P. H. Effect of defined lipopolysaccharide core defects on resistance of Salmonella typhimurium to freezing and thawing and other stresses. Appl Environ Microbiol. 1981 Nov;42(5):843–849. doi: 10.1128/aem.42.5.843-849.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bessalle R., Kapitkovsky A., Gorea A., Shalit I., Fridkin M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 1990 Nov 12;274(1-2):151–155. doi: 10.1016/0014-5793(90)81351-n. [DOI] [PubMed] [Google Scholar]
  10. Bevins C. L., Zasloff M. Peptides from frog skin. Annu Rev Biochem. 1990;59:395–414. doi: 10.1146/annurev.bi.59.070190.002143. [DOI] [PubMed] [Google Scholar]
  11. Boman H. G. Antibacterial peptides: key components needed in immunity. Cell. 1991 Apr 19;65(2):205–207. doi: 10.1016/0092-8674(91)90154-q. [DOI] [PubMed] [Google Scholar]
  12. Boman H. G., Faye I., Gudmundsson G. H., Lee J. Y., Lidholm D. A. Cell-free immunity in Cecropia. A model system for antibacterial proteins. Eur J Biochem. 1991 Oct 1;201(1):23–31. doi: 10.1111/j.1432-1033.1991.tb16252.x. [DOI] [PubMed] [Google Scholar]
  13. Boman H. G., Wade D., Boman I. A., Wåhlin B., Merrifield R. B. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 1989 Dec 18;259(1):103–106. doi: 10.1016/0014-5793(89)81505-4. [DOI] [PubMed] [Google Scholar]
  14. Brandenburg K., Seydel U. Investigation into the fluidity of lipopolysaccharide and free lipid A membrane systems by Fourier-transform infrared spectroscopy and differential scanning calorimetry. Eur J Biochem. 1990 Jul 20;191(1):229–236. doi: 10.1111/j.1432-1033.1990.tb19114.x. [DOI] [PubMed] [Google Scholar]
  15. Brass J. M. The cell envelope of gram-negative bacteria: new aspects of its function in transport and chemotaxis. Curr Top Microbiol Immunol. 1986;129:1–92. doi: 10.1007/978-3-642-71399-6_1. [DOI] [PubMed] [Google Scholar]
  16. Campanelli D., Detmers P. A., Nathan C. F., Gabay J. E. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J Clin Invest. 1990 Mar;85(3):904–915. doi: 10.1172/JCI114518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Carlsson A., Engström P., Palva E. T., Bennich H. Attacin, an antibacterial protein from Hyalophora cecropia, inhibits synthesis of outer membrane proteins in Escherichia coli by interfering with omp gene transcription. Infect Immun. 1991 Sep;59(9):3040–3045. doi: 10.1128/iai.59.9.3040-3045.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Carr C., Jr, Morrison D. C. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes. Infect Immun. 1985 Jul;49(1):84–89. doi: 10.1128/iai.49.1.84-89.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Casteels P., Ampe C., Jacobs F., Vaeck M., Tempst P. Apidaecins: antibacterial peptides from honeybees. EMBO J. 1989 Aug;8(8):2387–2391. doi: 10.1002/j.1460-2075.1989.tb08368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Casteels P., Ampe C., Riviere L., Van Damme J., Elicone C., Fleming M., Jacobs F., Tempst P. Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera). Eur J Biochem. 1990 Jan 26;187(2):381–386. doi: 10.1111/j.1432-1033.1990.tb15315.x. [DOI] [PubMed] [Google Scholar]
  21. Chapman J. S., Georgopapadakou N. H. Routes of quinolone permeation in Escherichia coli. Antimicrob Agents Chemother. 1988 Apr;32(4):438–442. doi: 10.1128/aac.32.4.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chitnis S. N., Prasad K. S., Bhargava P. M. Bacteriolytic activity of seminalplasmin. J Gen Microbiol. 1987 May;133(5):1265–1271. doi: 10.1099/00221287-133-5-1265. [DOI] [PubMed] [Google Scholar]
  23. Christensen B., Fink J., Merrifield R. B., Mauzerall D. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5072–5076. doi: 10.1073/pnas.85.14.5072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Coleman W. G., Jr, Leive L. Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane. J Bacteriol. 1979 Sep;139(3):899–910. doi: 10.1128/jb.139.3.899-910.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Conrad R. S., Galanos C. Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance. Antimicrob Agents Chemother. 1989 Oct;33(10):1724–1728. doi: 10.1128/aac.33.10.1724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cox A. D., Wilkinson S. G. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol Microbiol. 1991 Mar;5(3):641–646. doi: 10.1111/j.1365-2958.1991.tb00735.x. [DOI] [PubMed] [Google Scholar]
  27. Cruciani R. A., Barker J. L., Zasloff M., Chen H. C., Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792–3796. doi: 10.1073/pnas.88.9.3792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Danner R. L., Joiner K. A., Rubin M., Patterson W. H., Johnson N., Ayers K. M., Parrillo J. E. Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother. 1989 Sep;33(9):1428–1434. doi: 10.1128/aac.33.9.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Day D. F., Marceau-Day M. L., Ingram J. M. Protein-lipopolysaccharide interactions. 1. The reaction of lysozyme with Pseudomonas aeruginosa LPS. Can J Microbiol. 1978 Feb;24(2):196–199. doi: 10.1139/m78-035. [DOI] [PubMed] [Google Scholar]
  30. Dixon R. A., Chopra I. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother. 1986 May;29(5):781–788. doi: 10.1128/aac.29.5.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dixon R. A., Chopra I. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J Antimicrob Chemother. 1986 Nov;18(5):557–563. doi: 10.1093/jac/18.5.557. [DOI] [PubMed] [Google Scholar]
  32. Duclohier H., Molle G., Spach G. Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers. Biophys J. 1989 Nov;56(5):1017–1021. doi: 10.1016/S0006-3495(89)82746-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Duwe A. K., Rupar C. A., Horsman G. B., Vas S. I. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide. Antimicrob Agents Chemother. 1986 Aug;30(2):340–341. doi: 10.1128/aac.30.2.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ellison R. T., 3rd, Giehl T. J., LaForce F. M. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun. 1988 Nov;56(11):2774–2781. doi: 10.1128/iai.56.11.2774-2781.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ellison R. T., 3rd, LaForce F. M., Giehl T. J., Boose D. S., Dunn B. E. Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+. J Gen Microbiol. 1990 Jul;136(7):1437–1446. doi: 10.1099/00221287-136-7-1437. [DOI] [PubMed] [Google Scholar]
  36. Elsbach P., Weiss J., Franson R. C., Beckerdite-Quagliata S., Schneider A., Harris L. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem. 1979 Nov 10;254(21):11000–11009. [PubMed] [Google Scholar]
  37. Engström P., Carlsson A., Engström A., Tao Z. J., Bennich H. The antibacterial effect of attacins from the silk moth Hyalophora cecropia is directed against the outer membrane of Escherichia coli. EMBO J. 1984 Dec 20;3(13):3347–3351. doi: 10.1002/j.1460-2075.1984.tb02302.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Eustice D. C., Feldman P. A., Zajac I., Slee A. M. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob Agents Chemother. 1988 Aug;32(8):1218–1222. doi: 10.1128/aac.32.8.1218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Farley M. M., Shafer W. M., Spitznagel J. K. Lipopolysaccharide structure determines ionic and hydrophobic binding of a cationic antimicrobial neutrophil granule protein. Infect Immun. 1988 Jun;56(6):1589–1592. doi: 10.1128/iai.56.6.1589-1592.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Farmer S., Li Z. S., Hancock R. E. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother. 1992 Jan;29(1):27–33. doi: 10.1093/jac/29.1.27. [DOI] [PubMed] [Google Scholar]
  41. Frank R. W., Gennaro R., Schneider K., Przybylski M., Romeo D. Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. J Biol Chem. 1990 Nov 5;265(31):18871–18874. [PubMed] [Google Scholar]
  42. Gabay J. E., Scott R. W., Campanelli D., Griffith J., Wilde C., Marra M. N., Seeger M., Nathan C. F. Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5610–5614. doi: 10.1073/pnas.86.14.5610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Galanos C., Lüderitz O. Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem. 1975 Jun;54(2):603–610. doi: 10.1111/j.1432-1033.1975.tb04172.x. [DOI] [PubMed] [Google Scholar]
  44. Gennaro R., Skerlavaj B., Romeo D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun. 1989 Oct;57(10):3142–3146. doi: 10.1128/iai.57.10.3142-3146.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Goldman R., Kohlbrenner W., Lartey P., Pernet A. Antibacterial agents specifically inhibiting lipopolysaccharide synthesis. Nature. 1987 Sep 10;329(6135):162–164. doi: 10.1038/329162a0. [DOI] [PubMed] [Google Scholar]
  46. Gray P. W., Flaggs G., Leong S. R., Gumina R. J., Weiss J., Ooi C. E., Elsbach P. Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem. 1989 Jun 5;264(16):9505–9509. [PubMed] [Google Scholar]
  47. Greenwald G. I., Ganz T. Defensins mediate the microbicidal activity of human neutrophil granule extract against Acinetobacter calcoaceticus. Infect Immun. 1987 Jun;55(6):1365–1368. doi: 10.1128/iai.55.6.1365-1368.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hall J. B., Hino G. N., Inouye L., Nada A., Lau C. K., Read G. W. Antimicrobial action of compound 48/80--II mechanism of action. Biochem Pharmacol. 1983 Feb 1;32(3):449–453. doi: 10.1016/0006-2952(83)90522-1. [DOI] [PubMed] [Google Scholar]
  49. Hancock R. E. Alterations in outer membrane permeability. Annu Rev Microbiol. 1984;38:237–264. doi: 10.1146/annurev.mi.38.100184.001321. [DOI] [PubMed] [Google Scholar]
  50. Hancock R. E., Bell A. Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):713–720. doi: 10.1007/BF01975036. [DOI] [PubMed] [Google Scholar]
  51. Hancock R. E., Farmer S. W., Li Z. S., Poole K. Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob Agents Chemother. 1991 Jul;35(7):1309–1314. doi: 10.1128/aac.35.7.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Hancock R. E., Raffle V. J., Nicas T. I. Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1981 May;19(5):777–785. doi: 10.1128/aac.19.5.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hancock R. E. The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it. Antibiot Chemother (1971) 1985;36:95–102. doi: 10.1159/000410475. [DOI] [PubMed] [Google Scholar]
  54. Hancock R. E., Wong P. G. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother. 1984 Jul;26(1):48–52. doi: 10.1128/aac.26.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hardaway K. L., Buller C. S. Effect of ethylenediaminetetraacetate on phospholipids and outer membrane function in Escherichia coli. J Bacteriol. 1979 Jan;137(1):62–68. doi: 10.1128/jb.137.1.62-68.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hase S., Reitschel E. T. The chemical structure of the lipid A component of lipopolysaccharides from Chromobacterium violaceum NCTC 9694. Eur J Biochem. 1977 May 2;75(1):23–34. doi: 10.1111/j.1432-1033.1977.tb11500.x. [DOI] [PubMed] [Google Scholar]
  57. Helander I. M., Vaara M. Reversible binding of Salmonella typhimurium lipopolysaccharides by immobilized protamine. Eur J Biochem. 1987 Feb 16;163(1):51–55. doi: 10.1111/j.1432-1033.1987.tb10735.x. [DOI] [PubMed] [Google Scholar]
  58. Hirvas L., Koski P., Vaara M. Identification and sequence analysis of the gene mutated in the conditionally lethal outer membrane permeability mutant SS-C of Salmonella typhimurium. EMBO J. 1991 Apr;10(4):1017–1023. doi: 10.1002/j.1460-2075.1991.tb08036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Homma T., Nakae T. Effects of cations on the outer membrane permeability of Escherichia coli. Tokai J Exp Clin Med. 1982;7 (Suppl):171–175. [PubMed] [Google Scholar]
  60. Hook W. A., Tsuji S., Siraganian R. P. Magainin-2 releases histamine from rat mast cells. Proc Soc Exp Biol Med. 1990 Jan;193(1):50–55. doi: 10.3181/00379727-193-42989. [DOI] [PubMed] [Google Scholar]
  61. Hovde C. J., Gray B. H. Physiological effects of a bactericidal protein from human polymorphonuclear leukocytes on Pseudomonas aeruginosa. Infect Immun. 1986 Apr;52(1):90–95. doi: 10.1128/iai.52.1.90-95.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Hukari R., Helander I. M., Vaara M. Chain length heterogeneity of lipopolysaccharide released from Salmonella typhimurium by ethylenediaminetetraacetic acid or polycations. Eur J Biochem. 1986 Feb 3;154(3):673–676. doi: 10.1111/j.1432-1033.1986.tb09450.x. [DOI] [PubMed] [Google Scholar]
  63. Hultmark D., Engström A., Andersson K., Steiner H., Bennich H., Boman H. G. Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia. EMBO J. 1983;2(4):571–576. doi: 10.1002/j.1460-2075.1983.tb01465.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Hultmark D., Steiner H., Rasmuson T., Boman H. G. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem. 1980 May;106(1):7–16. doi: 10.1111/j.1432-1033.1980.tb05991.x. [DOI] [PubMed] [Google Scholar]
  65. Ito-Kagawa M., Koyama Y. Studies on the selectivity of action of colistin, colistin nonapeptide and colistin heptapeptide on the cell envelope of Escherichia coli. J Antibiot (Tokyo) 1984 Aug;37(8):926–928. doi: 10.7164/antibiotics.37.926. [DOI] [PubMed] [Google Scholar]
  66. Jit Sud I., Feingold D. S. Detection of agents that alter the bacterial cell surface. Antimicrob Agents Chemother. 1975 Jul;8(1):34–37. doi: 10.1128/aac.8.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Kaca W., Radziejewska-Lebrecht J., Bhat U. R. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis. Microbios. 1990;61(246):23–32. [PubMed] [Google Scholar]
  68. Kagan B. L., Selsted M. E., Ganz T., Lehrer R. I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A. 1990 Jan;87(1):210–214. doi: 10.1073/pnas.87.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kamio Y., Nikaido H. Outer membrane of Salmonella typhimurium: accessibility of phospholipid head groups to phospholipase c and cyanogen bromide activated dextran in the external medium. Biochemistry. 1976 Jun 15;15(12):2561–2570. doi: 10.1021/bi00657a012. [DOI] [PubMed] [Google Scholar]
  70. Katsu T., Kobayashi H., Fujita Y. Mode of action of gramicidin S on Escherichia coli membrane. Biochim Biophys Acta. 1986 Sep 11;860(3):608–619. doi: 10.1016/0005-2736(86)90560-2. [DOI] [PubMed] [Google Scholar]
  71. Katsu T., Shibata M., Fujita Y. Dication and trication which can increase the permeability of Escherichia coli outer membrane. Biochim Biophys Acta. 1985 Aug 8;818(1):61–66. doi: 10.1016/0005-2736(85)90138-5. [DOI] [PubMed] [Google Scholar]
  72. Katsu T., Tsuchiya T., Fujita Y. Dissipation of membrane potential of Escherichia coli cells induced by macromolecular polylysine. Biochem Biophys Res Commun. 1984 Jul 18;122(1):401–406. doi: 10.1016/0006-291x(84)90489-3. [DOI] [PubMed] [Google Scholar]
  73. Katsu T., Yoshimura S., Fujita Y. Increases in permeability of Escherichia coli outer membrane induced by polycations. FEBS Lett. 1984 Jan 23;166(1):175–178. doi: 10.1016/0014-5793(84)80067-8. [DOI] [PubMed] [Google Scholar]
  74. Kubesch P., Boggs J., Luciano L., Maass G., Tümmler B. Interaction of polymyxin B nonapeptide with anionic phospholipids. Biochemistry. 1987 Apr 21;26(8):2139–2149. doi: 10.1021/bi00382a012. [DOI] [PubMed] [Google Scholar]
  75. Kubesch P., Wehsling M., Tümmler B. Membrane permeability of Pseudomonas aeruginosa to 4-quinolones. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jun;265(1-2):197–202. doi: 10.1016/s0176-6724(87)80166-9. [DOI] [PubMed] [Google Scholar]
  76. LEIVE L. ACTINOMYCIN SENSITIVITY IN ESCHERICHIA COLI PRODUCED BY EDTA. Biochem Biophys Res Commun. 1965 Jan 4;18:13–17. doi: 10.1016/0006-291x(65)90874-0. [DOI] [PubMed] [Google Scholar]
  77. Labischinski H., Barnickel G., Bradaczek H., Naumann D., Rietschel E. T., Giesbrecht P. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol. 1985 Apr;162(1):9–20. doi: 10.1128/jb.162.1.9-20.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Lam C., Hildebrandt J., Schütze E., Wenzel A. F. Membrane-disorganizing property of polymyxin B nonapeptide. J Antimicrob Chemother. 1986 Jul;18(1):9–15. doi: 10.1093/jac/18.1.9. [DOI] [PubMed] [Google Scholar]
  79. Lam C., Turnowsky F., Högenauer G., Schütze E. Effect of a diazaborine derivative (Sa 84.474) on the virulence of Escherichia coli. J Antimicrob Chemother. 1987 Jul;20(1):37–45. doi: 10.1093/jac/20.1.37. [DOI] [PubMed] [Google Scholar]
  80. Lambert J., Keppi E., Dimarcq J. L., Wicker C., Reichhart J. M., Dunbar B., Lepage P., Van Dorsselaer A., Hoffmann J., Fothergill J. Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides. Proc Natl Acad Sci U S A. 1989 Jan;86(1):262–266. doi: 10.1073/pnas.86.1.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Lee J. Y., Boman A., Sun C. X., Andersson M., Jörnvall H., Mutt V., Boman H. G. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9159–9162. doi: 10.1073/pnas.86.23.9159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Lehrer R. I., Barton A., Daher K. A., Harwig S. S., Ganz T., Selsted M. E. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest. 1989 Aug;84(2):553–561. doi: 10.1172/JCI114198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Lehrer R. I., Barton A., Ganz T. Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J Immunol Methods. 1988 Apr 6;108(1-2):153–158. doi: 10.1016/0022-1759(88)90414-0. [DOI] [PubMed] [Google Scholar]
  84. Lehrer R. I., Ganz T. Antimicrobial polypeptides of human neutrophils. Blood. 1990 Dec 1;76(11):2169–2181. [PubMed] [Google Scholar]
  85. Lehrer R. I., Ganz T., Selsted M. E. Defensins: endogenous antibiotic peptides of animal cells. Cell. 1991 Jan 25;64(2):229–230. doi: 10.1016/0092-8674(91)90632-9. [DOI] [PubMed] [Google Scholar]
  86. Lehrer R. I., Selsted M. E., Szklarek D., Fleischmann J. Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun. 1983 Oct;42(1):10–14. doi: 10.1128/iai.42.1.10-14.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Lehrer R. I., Szklarek D., Barton A., Ganz T., Hamann K. J., Gleich G. J. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol. 1989 Jun 15;142(12):4428–4434. [PubMed] [Google Scholar]
  88. Leive L. Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun. 1965 Nov 22;21(4):290–296. doi: 10.1016/0006-291x(65)90191-9. [DOI] [PubMed] [Google Scholar]
  89. Leive L. The barrier function of the gram-negative envelope. Ann N Y Acad Sci. 1974 May 10;235(0):109–129. doi: 10.1111/j.1749-6632.1974.tb43261.x. [DOI] [PubMed] [Google Scholar]
  90. Lenney J. F., Siddiqui W. A., Schnell J. V., Furusawa E., Read G. W. Antimicrobial action of compound 48/80 against protozoa, bacteria, and fungi. J Pharm Sci. 1977 May;66(5):702–705. doi: 10.1002/jps.2600660524. [DOI] [PubMed] [Google Scholar]
  91. Loh B., Grant C., Hancock R. E. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Oct;26(4):546–551. doi: 10.1128/aac.26.4.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Lugtenberg B., Van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta. 1983 Mar 21;737(1):51–115. doi: 10.1016/0304-4157(83)90014-x. [DOI] [PubMed] [Google Scholar]
  93. MacDonald E. Screening for drugs blocking acetylcholine-activated ion channels and local anaesthetics with the isolated chick biventer cervicis preparation. Pharmacol Toxicol. 1988 Sep;63(3):193–198. doi: 10.1111/j.1600-0773.1988.tb00938.x. [DOI] [PubMed] [Google Scholar]
  94. Mannion B. A., Kalatzis E. S., Weiss J., Elsbach P. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. J Immunol. 1989 Apr 15;142(8):2807–2812. [PubMed] [Google Scholar]
  95. Mannion B. A., Weiss J., Elsbach P. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest. 1990 Mar;85(3):853–860. doi: 10.1172/JCI114512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Marra M. N., Wilde C. G., Griffith J. E., Snable J. L., Scott R. W. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol. 1990 Jan 15;144(2):662–666. [PubMed] [Google Scholar]
  97. Marvin H. J., Witholt B. A highly efficient procedure for the quantitative formation of intact and viable lysozyme spheroplasts from Escherichia coli. Anal Biochem. 1987 Aug 1;164(2):320–330. doi: 10.1016/0003-2697(87)90500-8. [DOI] [PubMed] [Google Scholar]
  98. McCashion R. N., Lynch W. H. Effects of polymyxin B nonapeptide on Aeromonas salmonicida. Antimicrob Agents Chemother. 1987 Sep;31(9):1414–1419. doi: 10.1128/aac.31.9.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Meyers E., Parker W. L., Brown W. E., Linnett P., Strominger J. L. EM49: a new polypeptide antibiotic active against cell membranes. Ann N Y Acad Sci. 1974 May 10;235(0):493–501. doi: 10.1111/j.1749-6632.1974.tb43286.x. [DOI] [PubMed] [Google Scholar]
  100. Mingeot-Leclercq M. P., Piret J., Tulkens P. M., Brasseur R. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition induced by aminoglycoside antibiotics--II. Conformational analysis. Biochem Pharmacol. 1990 Aug 1;40(3):499–506. doi: 10.1016/0006-2952(90)90548-y. [DOI] [PubMed] [Google Scholar]
  101. Miyata T., Tokunaga F., Yoneya T., Yoshikawa K., Iwanaga S., Niwa M., Takao T., Shimonishi Y. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J Biochem. 1989 Oct;106(4):663–668. doi: 10.1093/oxfordjournals.jbchem.a122913. [DOI] [PubMed] [Google Scholar]
  102. Mody R., Krishnamurthy S., Dave P. Influence of far-ultraviolet radiation on the permeability of the outer membrane of Escherichia coli. Can J Microbiol. 1989 Nov;35(11):1022–1030. doi: 10.1139/m89-170. [DOI] [PubMed] [Google Scholar]
  103. Moore R. A., Bates N. C., Hancock R. E. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother. 1986 Mar;29(3):496–500. doi: 10.1128/aac.29.3.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Moore R. A., Hancock R. E. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother. 1986 Dec;30(6):923–926. doi: 10.1128/aac.30.6.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Moore R. A., Woodruff W. A., Hancock R. E. Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa. Antibiot Chemother (1971) 1987;39:172–181. doi: 10.1159/000414344. [DOI] [PubMed] [Google Scholar]
  106. Morita T., Ohtsubo S., Nakamura T., Tanaka S., Iwanaga S., Ohashi K., Niwa M. Isolation and biological activities of limulus anticoagulant (anti-LPS factor) which interacts with lipopolysaccharide (LPS). J Biochem. 1985 Jun;97(6):1611–1620. doi: 10.1093/oxfordjournals.jbchem.a135218. [DOI] [PubMed] [Google Scholar]
  107. Muta T., Miyata T., Tokunaga F., Nakamura T., Iwanaga S. Primary structure of anti-lipopolysaccharide factor from American horseshoe crab, Limulus polyphemus. J Biochem. 1987 Jun;101(6):1321–1330. doi: 10.1093/oxfordjournals.jbchem.a121999. [DOI] [PubMed] [Google Scholar]
  108. Nakae T. Outer-membrane permeability of bacteria. Crit Rev Microbiol. 1986;13(1):1–62. doi: 10.3109/10408418609108734. [DOI] [PubMed] [Google Scholar]
  109. Nakamura T., Furunaka H., Miyata T., Tokunaga F., Muta T., Iwanaga S., Niwa M., Takao T., Shimonishi Y. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J Biol Chem. 1988 Nov 15;263(32):16709–16713. [PubMed] [Google Scholar]
  110. Neu H. C., Chou J. Release of surface enzymes in Enterobacteriaceae by osmotic shock. J Bacteriol. 1967 Dec;94(6):1934–1945. doi: 10.1128/jb.94.6.1934-1945.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Neu H. C., Heppel L. A. The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem. 1965 Sep;240(9):3685–3692. [PubMed] [Google Scholar]
  112. Nicas T. I., Hancock R. E. Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. J Gen Microbiol. 1983 Feb;129(2):509–517. doi: 10.1099/00221287-129-2-509. [DOI] [PubMed] [Google Scholar]
  113. Nicas T. I., Hancock R. E. Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol. 1980 Aug;143(2):872–878. doi: 10.1128/jb.143.2.872-878.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Nikaido H., Nakae T. The outer membrane of Gram-negative bacteria. Adv Microb Physiol. 1979;20:163–250. doi: 10.1016/s0065-2911(08)60208-8. [DOI] [PubMed] [Google Scholar]
  115. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989 Nov;33(11):1831–1836. doi: 10.1128/aac.33.11.1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Nikaido H. Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta. 1976 Apr 16;433(1):118–132. doi: 10.1016/0005-2736(76)90182-6. [DOI] [PubMed] [Google Scholar]
  117. Nikaido H. Role of permeability barriers in resistance to beta-lactam antibiotics. Pharmacol Ther. 1985;27(2):197–231. doi: 10.1016/0163-7258(85)90069-5. [DOI] [PubMed] [Google Scholar]
  118. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32. doi: 10.1128/mr.49.1.1-32.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Odeberg H., Olsson I. Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun. 1976 Dec;14(6):1269–1275. doi: 10.1128/iai.14.6.1269-1275.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Odeberg H., Olsson I. Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun. 1976 Dec;14(6):1276–1283. doi: 10.1128/iai.14.6.1276-1283.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Ohashi K., Niwa M., Nakamura T., Morita T., Iwanaga S. Anti-LPS factor in the horseshoe crab, Tachypleus tridentatus. Its hemolytic activity on the red blood cell sensitized with lipopolysaccharide. FEBS Lett. 1984 Oct 15;176(1):207–210. doi: 10.1016/0014-5793(84)80942-4. [DOI] [PubMed] [Google Scholar]
  122. Ohno N., Morrison D. C. Effects of lipopolysaccharide chemotype structure on binding and inactivation of hen egg lysozyme. Eur J Biochem. 1989 Dec 22;186(3):621–627. doi: 10.1111/j.1432-1033.1989.tb15252.x. [DOI] [PubMed] [Google Scholar]
  123. Ohno N., Morrison D. C. Lipopolysaccharide interaction with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J Biol Chem. 1989 Mar 15;264(8):4434–4441. [PubMed] [Google Scholar]
  124. Ooi C. E., Weiss J., Doerfler M. E., Elsbach P. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med. 1991 Sep 1;174(3):649–655. doi: 10.1084/jem.174.3.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Ooi C. E., Weiss J., Elsbach P., Frangione B., Mannion B. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem. 1987 Nov 5;262(31):14891–14894. [PubMed] [Google Scholar]
  126. Pereira H. A., Spitznagel J. K., Winton E. F., Shafer W. M., Martin L. E., Guzman G. S., Pohl J., Scott R. W., Marra M. N., Kinkade J. M., Jr The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population. Blood. 1990 Aug 15;76(4):825–834. [PubMed] [Google Scholar]
  127. Peterson A. A., Fesik S. W., McGroarty E. J. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother. 1987 Feb;31(2):230–237. doi: 10.1128/aac.31.2.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Peterson A. A., Hancock R. E., McGroarty E. J. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol. 1985 Dec;164(3):1256–1261. doi: 10.1128/jb.164.3.1256-1261.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Pohl J., Pereira H. A., Martin N. M., Spitznagel J. K. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett. 1990 Oct 15;272(1-2):200–204. doi: 10.1016/0014-5793(90)80484-z. [DOI] [PubMed] [Google Scholar]
  130. REPASKE R. Lysis of gram-negative organisms and the role of versene. Biochim Biophys Acta. 1958 Nov;30(2):225–232. doi: 10.1016/0006-3002(58)90044-1. [DOI] [PubMed] [Google Scholar]
  131. Rana F. R., Macias E. A., Sultany C. M., Modzrakowski M. C., Blazyk J. Interactions between magainin 2 and Salmonella typhimurium outer membranes: effect of lipopolysaccharide structure. Biochemistry. 1991 Jun 18;30(24):5858–5866. doi: 10.1021/bi00238a008. [DOI] [PubMed] [Google Scholar]
  132. Ray B., Jezeski J. J., Busta F. F. Repair of injury in freeze-dried Salmonella anatum. Appl Microbiol. 1971 Sep;22(3):401–407. doi: 10.1128/am.22.3.401-407.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Roantree R. J., Kuo T. T., MacPhee D. G. The effect of defined lipopolysaccharide core defects upon antibiotic resistances of Salmonella typhimurium. J Gen Microbiol. 1977 Dec;103(2):223–234. doi: 10.1099/00221287-103-2-223. [DOI] [PubMed] [Google Scholar]
  134. Rosenthal K. S., Storm D. R. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. J Antibiot (Tokyo) 1977 Dec;30(12):1087–1092. doi: 10.7164/antibiotics.30.1087. [DOI] [PubMed] [Google Scholar]
  135. Sahl H. G. Bactericidal cationic peptides involved in bacterial antagonism and host defence. Microbiol Sci. 1985 Jul;2(7):212–217. [PubMed] [Google Scholar]
  136. Said A. A., Livermore D. M., Williams R. J. Expression of H1 outer-membrane protein of Pseudomonas aeruginosa in relation to sensitivity to EDTA and polymyxin B. J Med Microbiol. 1987 Nov;24(3):267–274. doi: 10.1099/00222615-24-3-267. [DOI] [PubMed] [Google Scholar]
  137. Sanderson K. E., MacAlister T., Costerton J. W., Cheng K. J. Permeability of lipopolysaccharide-deficient (rough) mutants of Salmonella typhimurium to antibiotics, lysozyme, and other agents. Can J Microbiol. 1974 Aug;20(8):1135–1145. doi: 10.1139/m74-176. [DOI] [PubMed] [Google Scholar]
  138. Sawyer J. G., Martin N. L., Hancock R. E. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun. 1988 Mar;56(3):693–698. doi: 10.1128/iai.56.3.693-698.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Schindler M., Osborn M. J. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry. 1979 Oct 2;18(20):4425–4430. doi: 10.1021/bi00587a024. [DOI] [PubMed] [Google Scholar]
  140. Schindler P. R., Teuber M. Ultrastructural study of Salmonella typhimurium treated with membrane-active agents: specific reaction dansylchloride with cell envelope components. J Bacteriol. 1978 Jul;135(1):198–206. doi: 10.1128/jb.135.1.198-206.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Schröder G., Brandenburg K., Seydel U. Polymyxin B induces transient permeability fluctuations in asymmetric planar lipopolysaccharide/phospholipid bilayers. Biochemistry. 1992 Jan 28;31(3):631–638. doi: 10.1021/bi00118a001. [DOI] [PubMed] [Google Scholar]
  142. Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and function of lipopolysaccharide binding protein. Science. 1990 Sep 21;249(4975):1429–1431. doi: 10.1126/science.2402637. [DOI] [PubMed] [Google Scholar]
  143. Scudamore R. A., Beveridge T. J., Goldner M. Outer-membrane penetration barriers as components of intrinsic resistance to beta-lactam and other antibiotics in Escherichia coli K-12. Antimicrob Agents Chemother. 1979 Feb;15(2):182–189. doi: 10.1128/aac.15.2.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Selsted M. E., Szklarek D., Lehrer R. I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 1984 Jul;45(1):150–154. doi: 10.1128/iai.45.1.150-154.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Seltmann G., Wolter E. J. Effect of nourseothricin (streptothricin) on the outer membrane of sensitive and resistant Escherichia coli strains. J Basic Microbiol. 1987;27(3):139–146. doi: 10.1002/jobm.3620270305. [DOI] [PubMed] [Google Scholar]
  146. Shafer W. M., Engle S. A., Martin L. E., Spitznagel J. K. Killing of Proteus mirabilis by polymorphonuclear leukocyte granule proteins: evidence for species specificity by antimicrobial proteins. Infect Immun. 1988 Jan;56(1):51–53. doi: 10.1128/iai.56.1.51-53.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Shafer W. M., Martin L. E., Spitznagel J. K. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun. 1984 Jul;45(1):29–35. doi: 10.1128/iai.45.1.29-35.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Shafer W. M., Martin L. E., Spitznagel J. K. Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes. Infect Immun. 1986 Sep;53(3):651–655. doi: 10.1128/iai.53.3.651-655.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Shafer W. M., Onunka V. C., Martin L. E. Antigonococcal activity of human neutrophil cathepsin G. Infect Immun. 1986 Oct;54(1):184–188. doi: 10.1128/iai.54.1.184-188.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Shafer W. M., Pohl J., Onunka V. C., Bangalore N., Travis J. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem. 1991 Jan 5;266(1):112–116. [PubMed] [Google Scholar]
  151. Shima S., Matsuoka H., Iwamoto T., Sakai H. Antimicrobial action of epsilon-poly-L-lysine. J Antibiot (Tokyo) 1984 Nov;37(11):1449–1455. doi: 10.7164/antibiotics.37.1449. [DOI] [PubMed] [Google Scholar]
  152. Shlaes D. M., Shlaes J. H., Davies J., Williamson R. Escherichia coli susceptible to glycopeptide antibiotics. Antimicrob Agents Chemother. 1989 Feb;33(2):192–197. doi: 10.1128/aac.33.2.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Sidorczyk Z., Zähringer U., Rietschel E. T. Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem. 1983 Dec 1;137(1-2):15–22. doi: 10.1111/j.1432-1033.1983.tb07789.x. [DOI] [PubMed] [Google Scholar]
  154. Sitaram N., Nagaraj R. A synthetic 13-residue peptide corresponding to the hydrophobic region of bovine seminalplasmin has antibacterial activity and also causes lysis of red blood cells. J Biol Chem. 1990 Jun 25;265(18):10438–10442. [PubMed] [Google Scholar]
  155. Skerlavaj B., Romeo D., Gennaro R. Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins. Infect Immun. 1990 Nov;58(11):3724–3730. doi: 10.1128/iai.58.11.3724-3730.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Spitznagel J. K. Antibiotic proteins of human neutrophils. J Clin Invest. 1990 Nov;86(5):1381–1386. doi: 10.1172/JCI114851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Stinavage P., Martin L. E., Spitznagel J. K. O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophils. Infect Immun. 1989 Dec;57(12):3894–3900. doi: 10.1128/iai.57.12.3894-3900.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Storm D. R., Rosenthal K. S., Swanson P. E. Polymyxin and related peptide antibiotics. Annu Rev Biochem. 1977;46:723–763. doi: 10.1146/annurev.bi.46.070177.003451. [DOI] [PubMed] [Google Scholar]
  159. Sukupolvi S., Vaara M. Salmonella typhimurium and Escherichia coli mutants with increased outer membrane permeability to hydrophobic compounds. Biochim Biophys Acta. 1989 Dec 6;988(3):377–387. doi: 10.1016/0304-4157(89)90011-7. [DOI] [PubMed] [Google Scholar]
  160. Tamaki S., Sato T., Matsuhashi M. Role of lipopolysaccharides in antibiotic resistance and bacteriophage adsorption of Escherichia coli K-12. J Bacteriol. 1971 Mar;105(3):968–975. doi: 10.1128/jb.105.3.968-975.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Tecoma E. S., Wu D. Membrane deenergization by colicin K affects fluorescence of exogenously added but not biosynthetically esterified parinaric acid probes in Escherichia coli. J Bacteriol. 1980 Jun;142(3):931–938. doi: 10.1128/jb.142.3.931-938.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Tobias P. S., Mathison J. C., Ulevitch R. J. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem. 1988 Sep 25;263(27):13479–13481. [PubMed] [Google Scholar]
  163. Tobias P. S., Soldau K., Ulevitch R. J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem. 1989 Jun 25;264(18):10867–10871. [PubMed] [Google Scholar]
  164. Tosteson M. T., Tosteson D. C. Activation and inactivation of melittin channels. Biophys J. 1984 Jan;45(1):112–114. doi: 10.1016/S0006-3495(84)84130-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Traub W. H., Kohl K. H., Spohr M., Bauer D. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens. Chemotherapy. 1988;34(3):195–201. doi: 10.1159/000238571. [DOI] [PubMed] [Google Scholar]
  166. Tsuchido T., Aoki I., Takano M. Interaction of the fluorescent dye 1-N-phenylnaphthylamine with Escherichia coli cells during heat stress and recovery from heat stress. J Gen Microbiol. 1989 Jul;135(7):1941–1947. doi: 10.1099/00221287-135-7-1941. [DOI] [PubMed] [Google Scholar]
  167. Tsuchido T., Takano M. Sensitization by heat treatment of Escherichia coli K-12 cells to hydrophobic antibacterial compounds. Antimicrob Agents Chemother. 1988 Nov;32(11):1680–1683. doi: 10.1128/aac.32.11.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Turnowsky F., Fuchs K., Jeschek C., Högenauer G. envM genes of Salmonella typhimurium and Escherichia coli. J Bacteriol. 1989 Dec;171(12):6555–6565. doi: 10.1128/jb.171.12.6555-6565.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Uratani Y. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope. J Bacteriol. 1982 Feb;149(2):523–528. doi: 10.1128/jb.149.2.523-528.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Vaara M. Analytical and preparative high-performance liquid chromatography of the papain-cleaved derivative of polymyxin B. J Chromatogr. 1988 Jun 10;441(2):423–430. doi: 10.1016/s0021-9673(01)83889-9. [DOI] [PubMed] [Google Scholar]
  171. Vaara M. Antimicrobial susceptibility of Salmonella typhimurium carrying the outer membrane permeability mutation SS-B. Antimicrob Agents Chemother. 1990 May;34(5):853–857. doi: 10.1128/aac.34.5.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Vaara M. Do salicylates and ascorbate increase the outer membrane permeability to hydrophobic antibiotics in Pseudomonas aeruginosa? Drugs Exp Clin Res. 1990;16(11):569–574. [PubMed] [Google Scholar]
  173. Vaara M. Increased outer membrane resistance to ethylenediaminetetraacetate and cations in novel lipid A mutants. J Bacteriol. 1981 Nov;148(2):426–434. doi: 10.1128/jb.148.2.426-434.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Vaara M., Jaakkola J. Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs. Antimicrob Agents Chemother. 1989 Oct;33(10):1741–1747. doi: 10.1128/aac.33.10.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Vaara M., Plachy W. Z., Nikaido H. Partitioning of hydrophobic probes into lipopolysaccharide bilayers. Biochim Biophys Acta. 1990 May 9;1024(1):152–158. doi: 10.1016/0005-2736(90)90218-d. [DOI] [PubMed] [Google Scholar]
  176. Vaara M. The effect of oligolysines Lys-3, Lys-4, and Lys-5 on the outer membrane permeability of Pseudomonas aeruginosa. FEMS Microbiol Lett. 1990 Jan 15;55(1-2):15–19. doi: 10.1016/0378-1097(90)90160-r. [DOI] [PubMed] [Google Scholar]
  177. Vaara M. The outer membrane as the penetration barrier against mupirocin in gram-negative enteric bacteria. J Antimicrob Chemother. 1992 Feb;29(2):221–222. doi: 10.1093/jac/29.2.221. [DOI] [PubMed] [Google Scholar]
  178. Vaara M. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide. Drugs Exp Clin Res. 1991;17(9):437–443. [PubMed] [Google Scholar]
  179. Vaara M., Vaara T., Jensen M., Helander I., Nurminen M., Rietschel E. T., Mäkelä P. H. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett. 1981 Jun 29;129(1):145–149. doi: 10.1016/0014-5793(81)80777-6. [DOI] [PubMed] [Google Scholar]
  180. Vaara M., Vaara T. Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob Agents Chemother. 1981 Apr;19(4):578–583. doi: 10.1128/aac.19.4.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Vaara M., Vaara T. Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother. 1983 Jul;24(1):114–122. doi: 10.1128/aac.24.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Vaara M., Vaara T. Polycations sensitize enteric bacteria to antibiotics. Antimicrob Agents Chemother. 1983 Jul;24(1):107–113. doi: 10.1128/aac.24.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Vaara M., Vaara T., Sarvas M. Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium. J Bacteriol. 1979 Aug;139(2):664–667. doi: 10.1128/jb.139.2.664-667.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Vaara M., Vaara T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature. 1983 Jun 9;303(5917):526–528. doi: 10.1038/303526a0. [DOI] [PubMed] [Google Scholar]
  185. Vaara M., Viljanen P. Binding of polymyxin B nonapeptide to gram-negative bacteria. Antimicrob Agents Chemother. 1985 Apr;27(4):548–554. doi: 10.1128/aac.27.4.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Vaara M., Viljanen P., Vaara T., Mäkelä P. H. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J Immunol. 1984 May;132(5):2582–2589. [PubMed] [Google Scholar]
  187. Viljanen P., Koski P., Vaara M. Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane. Infect Immun. 1988 Sep;56(9):2324–2329. doi: 10.1128/iai.56.9.2324-2329.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Viljanen P., Käyhty H., Vaara M., Vaara T. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide. Can J Microbiol. 1986 Jan;32(1):66–69. doi: 10.1139/m86-013. [DOI] [PubMed] [Google Scholar]
  189. Viljanen P., Matsunaga H., Kimura Y., Vaara M. The outer membrane permeability-increasing action of deacylpolymyxins. J Antibiot (Tokyo) 1991 May;44(5):517–523. doi: 10.7164/antibiotics.44.517. [DOI] [PubMed] [Google Scholar]
  190. Viljanen P., Vaara M. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother. 1984 Jun;25(6):701–705. doi: 10.1128/aac.25.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Voitenko V. G., Bayramashvili D. I., Zebrev A. I., Zinchenko A. A. Relationship between structure and histamine releasing action of polymyxin B and its analogues. Agents Actions. 1990 Apr;30(1-2):153–156. doi: 10.1007/BF01969025. [DOI] [PubMed] [Google Scholar]
  192. Voss J. G. Effects of organic cations on the gram-negative cell wall and their bactericidal activity with ethylenediaminetetra-acetate and surface active agents. J Gen Microbiol. 1967 Sep;48(3):391–400. doi: 10.1099/00221287-48-3-391. [DOI] [PubMed] [Google Scholar]
  193. Vuorio R., Vaara M. The lipid A biosynthesis mutation lpxA2 of Escherichia coli results in drastic antibiotic supersusceptibility. Antimicrob Agents Chemother. 1992 Apr;36(4):826–829. doi: 10.1128/aac.36.4.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. WARREN G. H., GRAY J., YURCHENCO J. A. Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme. J Bacteriol. 1957 Dec;74(6):788–793. doi: 10.1128/jb.74.6.788-793.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Wade D., Boman A., Wåhlin B., Drain C. M., Andreu D., Boman H. G., Merrifield R. B. All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4761–4765. doi: 10.1073/pnas.87.12.4761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Warren H. S., Kania S. A., Siber G. R. Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob Agents Chemother. 1985 Jul;28(1):107–112. doi: 10.1128/aac.28.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Wasiluk K. R., Skubitz K. M., Gray B. H. Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa. Infect Immun. 1991 Nov;59(11):4193–4200. doi: 10.1128/iai.59.11.4193-4200.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Wee S., Wilkinson B. J. Increased outer membrane ornithine-containing lipid and lysozyme penetrability of Paracoccus denitrificans grown in a complex medium deficient in divalent cations. J Bacteriol. 1988 Jul;170(7):3283–3286. doi: 10.1128/jb.170.7.3283-3286.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Weintraub A., Zähringer U., Wollenweber H. W., Seydel U., Rietschel E. T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem. 1989 Aug 1;183(2):425–431. doi: 10.1111/j.1432-1033.1989.tb14945.x. [DOI] [PubMed] [Google Scholar]
  200. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978 Apr 25;253(8):2664–2672. [PubMed] [Google Scholar]
  201. Weiss J., Franson R. C., Beckerdite S., Schmeidler K., Elsbach P. Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest. 1975 Jan;55(1):33–42. doi: 10.1172/JCI107915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Weiss J., Muello K., Victor M., Elsbach P. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol. 1984 Jun;132(6):3109–3115. [PubMed] [Google Scholar]
  203. Weiss J., Victor M., Elsbach P. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Invest. 1983 Mar;71(3):540–549. doi: 10.1172/JCI110798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Williams P. D., Bennett D. B., Gleason C. R., Hottendorf G. H. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother. 1987 Apr;31(4):570–574. doi: 10.1128/aac.31.4.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Yamaguchi A., Ohmori H., Kaneko-Ohdera M., Nomura T., Sawai T. Delta pH-dependent accumulation of tetracycline in Escherichia coli. Antimicrob Agents Chemother. 1991 Jan;35(1):53–56. doi: 10.1128/aac.35.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Yamashita T., Saito K. Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides. Infect Immun. 1989 Aug;57(8):2405–2409. doi: 10.1128/iai.57.8.2405-2409.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Young K., Silver L. L. Leakage of periplasmic enzymes from envA1 strains of Escherichia coli. J Bacteriol. 1991 Jun;173(12):3609–3614. doi: 10.1128/jb.173.12.3609-3614.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449–5453. doi: 10.1073/pnas.84.15.5449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Zasloff M., Martin B., Chen H. C. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A. 1988 Feb;85(3):910–913. doi: 10.1073/pnas.85.3.910. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES